2020
DOI: 10.1089/mdr.2019.0465
|View full text |Cite
|
Sign up to set email alerts
|

Antimicrobial Susceptibility of Caprine and Ovine Mycoplasma ovipneumoniae Isolates

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
5
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 16 publications
1
5
0
Order By: Relevance
“…Our results are in overall agreement with the recent results of Maksimović et al, i.e. strains with mostly low MIC values whatever the drug considered, although significant higher MIC values were obtained from goat strains with oxytetracycline, tylosin and enrofloxacin compared to sheep (Maksimović et al, 2020a). Some MIC discrepancies in the only common strain analysed in the two studies, namely Y98, were observed for aminosides, phenicols and macrolides.…”
Section: Antimicrobial Resistancesupporting
confidence: 92%
See 1 more Smart Citation
“…Our results are in overall agreement with the recent results of Maksimović et al, i.e. strains with mostly low MIC values whatever the drug considered, although significant higher MIC values were obtained from goat strains with oxytetracycline, tylosin and enrofloxacin compared to sheep (Maksimović et al, 2020a). Some MIC discrepancies in the only common strain analysed in the two studies, namely Y98, were observed for aminosides, phenicols and macrolides.…”
Section: Antimicrobial Resistancesupporting
confidence: 92%
“…Surprisingly, the host influence on MIC distribution remained limited, being statistically significant only for spectinomycin, oxytetracycline, tilmicosin and florfenicol but within a range of one dilution only. The host species difference evidenced by Maksimović et al appeared more marked for enrofloxacin (MIC90 difference of three dilutions), oxytetracycline (seven dilutions) and tylosin (six dilutions), suggesting different patterns of use between the two countries (Maksimović et al, 2020a). In France, the situation of M. ovipneumoniae contrasts with that previously observed for the M. agalactiae species, one of the agents causing contagious agalactia syndrome in small ruminants (Poumarat et al, 2016), for which the animal host influence was marked for several drugs.…”
Section: Antimicrobial Resistancementioning
confidence: 93%
“…Currently, there are few global surveillance records for M. ovipneumoniae and some gaps in basic research have resulted from nutritionally limited conditions for in vitro growth (24–72 h with a peak at 48 h), a spherical morphology (pear, flask-shaped cells, and filaments), and a lack of fried egg-like morphology on agar plates [ 9 , 10 ]. After isolation, microbial identification mainly depends on additional tests such as biochemical testing, PCR, Sanger sequencing, serological testing, or matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) [ 1 , 11 13 ].…”
Section: Introductionmentioning
confidence: 99%
“…However, the control of M. ovipneumoniae infection primarily relies on antimicrobial therapy because of its inherent resistance to cell wall-targeting antimicrobial drugs such as β-lactams and glycopeptide antibiotics. Oxytetracycline and macrolide antibiotics can alleviate clinical symptoms, but fail to eradicate the infection [56]. Notably, fluoroquinolones, tetracyclines, and macrolides have demonstrated efficacy in vitro to treat Mycoplasma pneumoniae [57].…”
Section: Discussionmentioning
confidence: 99%